Validating Alzheimer's disease micro RNAs using next‐generation sequencing
Andreas Keller(Helmholtz Institute for Pharmaceutical Research Saarland), Eckart Meese(Saarland University), Christina Backes(Saarland University), Jan Haas(Heidelberg University), Benjamin Meder(Heidelberg University), Klemens Ruprecht(Charité - Universitätsmedizin Berlin), Cord Stähler(Siemens Healthineers (Germany)), Daniel Sickert(Siemens Healthineers (Germany)), Walter Maetzler(Christian-Albrechts-Universität zu Kiel), Maximilian L. Würstle(Siemens Healthineers (Germany)), Christoph Ruschil, Valentina Galata(Saarland University), Christian Deuschle(German Center for Neurodegenerative Diseases), Daniela Berg(Christian-Albrechts-Universität zu Kiel), M. Gogol(Krankenhaus Lindenbrunn), Petra Leidinger(Institute of Human Genetics)
Cited by 69
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846